Daniel DiRenzo
Impact in
- Immunology top 5%
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- Atherosclerosis and Cardiovascular Diseases
- Physiology top 5%
- Erythrocyte Function and Pathophysiology
Papers in
- Physiology 18
- Adenosine and Purinergic Signaling 18
- Oncology 14
- Cancer Immunotherapy and Biomarkers 10
- Peptidase Inhibition and Analysis 4
- Co-authors
- Nicholas J. Leeper (3 shared papers)Clint L. Miller (2 shared papers)Thomas Quertermous (2 shared papers)Yoko Kojima (2 shared papers)Vivek Nanda (2 shared papers)Andrew J. Connolly (2 shared papers)Jianqin Ye (2 shared papers)Lars Mäegdefessel (2 shared papers)
- Journals
- Cancer Research (10 papers)Cancer Immunology Research (3 papers)Circulation Research (2 papers)Annals of Oncology (2 papers)Journal of Visualized Experiments (2 papers)
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Daniel DiRenzo
35 papers receiving 1.0k citations
Daniel DiRenzo's Hit Papers
Peers
Comparison fields: 5 of 84
- Immunology 474
- Physiology 52
- Cancer Research 121
- Molecular Biology 478
- Oncology 170
Countries citing papers authored by Daniel DiRenzo
This map shows the geographic impact of Daniel DiRenzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel DiRenzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel DiRenzo more than expected).
Fields of papers citing papers by Daniel DiRenzo
This network shows the impact of papers produced by Daniel DiRenzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel DiRenzo. The network helps show where Daniel DiRenzo may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel DiRenzo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis Hit paper breakdown → | 2016 | 500 |
| 2 | 2016 | 88 | |
| 3 | 2012 | 50 | |
| 4 | 2015 | 45 | |
| 5 | 2014 | 40 | |
| 6 | 2016 | 33 | |
| 7 | 2014 | 32 | |
| 8 | 2010 | 31 | |
| 9 | 2017 | 25 | |
| 10 | 2017 | 24 | |
| 11 | 2016 | 23 | |
| 12 | 2021 | 21 | |
| 13 | 2014 | 21 | |
| 14 | 2015 | 15 | |
| 15 | 2019 | 15 | |
| 16 | 2011 | 11 | |
| 17 | 2018 | 9 | |
| 18 | 2011 | 9 | |
| 19 | 2019 | 7 | |
| 20 | 2015 | 7 |
About Daniel DiRenzo
Daniel DiRenzo is a scholar working on Physiology, Oncology, Molecular Biology, Biomedical Engineering and Surgery, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (18 papers), Cancer Immunotherapy and Biomarkers (10 papers), Nanoplatforms for cancer theranostics (7 papers), TGF-β signaling in diseases (4 papers), Peptidase Inhibition and Analysis (4 papers), Click Chemistry and Applications (4 papers), Pancreatic function and diabetes (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Immunology (474 citations), Physiology (52 citations), Cancer Research (121 citations), Molecular Biology (478 citations) and Oncology (170 citations). Daniel DiRenzo has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Nicholas J. Leeper, Clint L. Miller, Thomas Quertermous, Yoko Kojima, Vivek Nanda, Andrew J. Connolly, Jianqin Ye, Lars Mäegdefessel, Ulf Hedin and Kelly M. McKenna. Their work appears in journals such as Cancer Research, Cancer Immunology Research, Circulation Research, Annals of Oncology and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.